Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis (Q58023968)
Jump to navigation
Jump to search
scientific article published on 01 April 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis |
scientific article published on 01 April 2007 |
Statements
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis (English)
Stefan Fruehauf
Julian Topaly
Thomas Fischer
Bertold Emmerich
Peter Schuld
Leopold Balleisen
Rüdiger Hehlmann
Martin C Müller
1 reference